N-Nitroso Enzalutamide Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Enzalutamide is used to treat castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone), and metastatic castration-sensitive prostate cancer (prostate cancer that has spread to other parts of the body and responds to a hormone therapy or surgical.N-Nitroso Enzalutamide Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Enzalutamide Impurity 1 CAS NO:NA chemically represented as N-(4-Cyano-3-(trifluoromethyl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of N-Nitroso Enzalutamide Impurity 1.We supply N-Nitroso Enzalutamide Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142788 |
| CAS No | NA |
| Mol.F. | C13H10N2O3S2 |
| Mol.Wt. | 306.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142789 |
| CAS No | 1698-25-5 |
| Mol.F. | C17H19N3O |
| Mol.Wt. | 281.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142790 |
| CAS No | NA |
| Mol.F. | C13H17N3O |
| Mol.Wt. | 231.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142791 |
| CAS No | NA |
| Mol.F. | C11H15N3O |
| Mol.Wt. | 205.3 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142792 |
| CAS No | NA |
| Mol.F. | C11H15N3O |
| Mol.Wt. | 205.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142793 |
| CAS No | NA |
| Mol.F. | C14H19N3O3 |
| Mol.Wt. | 277.3g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142794 |
| CAS No | 6947-36-0 |
| Mol.F. | C14H14N2O3 |
| Mol.Wt. | 258.27 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142795 |
| CAS No | NA |
| Mol.F. | C25H27N7O5 |
| Mol.Wt. | 505.53 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142796 |
| CAS No | NA |
| Mol.F. | C20H32N43O4 |
| Mol.Wt. | 392.50 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142797 |
| CAS No | NA |
| Mol.F. | C20H32N43O4 |
| Mol.Wt. | 392.50 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142798 |
| CAS No | NA |
| Mol.F. | C25H30N4O5 |
| Mol.Wt. | 466.54 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142799 |
| CAS No | NA |
| Mol.F. | C11H12N2O4 |
| Mol.Wt. | 236.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142800 |
| CAS No | NA |
| Mol.F. | C8H6N2O2 |
| Mol.Wt. | 162.15 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142801 |
| CAS No | NA |
| Mol.F. | C11H11ClN2O3 |
| Mol.Wt. | 254.67 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142802 |
| CAS No | NA |
| Mol.F. | C11H10N2O3 |
| Mol.Wt. | 218.21 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142803 |
| CAS No | NA |
| Mol.F. | C28H19Cl4N3O5 |
| Mol.Wt. | 619.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |